So the "orphan drug" desination they're going after (or already have in hand) is not for one of the big diseases we hear so much mention of (diabetes, alzheimers etc) but rather they're looking at something much rarer....thanks for clearing that up.

Also kelsee, great observation on the non existent volume....man has it ever dried up. Assuming the thesis about smart money accumulation is right, then trading this thin could prove problematic from those looking to acquire shares...If there are retailers with holdings numbering in the tens of thousands, it follows that the thought of selling some shares could be scary with trading this light.

Imagine someone with 100K shares for example, and say they were looking to reduct their exposure here to the tune of 25,000.....that would be greater than today's entire volume by a sizeable margin.

Oh, but one thing....stop picking on the Leafs, its like tripping a blind person.